# Angiodynamics Inc: filings

ANGO · Nasdaq · CIK 1275187 · [Healthcare](/sectors/healthcare.md) · fiscal year ends May 31

Pages: [Overview](/companies/ango.md) · [Financials](/companies/ango/financials.md) · [Filings](/companies/ango/filings.md) · [Insiders](/companies/ango/insiders.md)

## Reports and events: 312 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 605, 8-K 203, SC 13G/A 72, 10-Q 54, 3 38, DEFA14A 29, 4/A 19, 10-K 18, DEF 14A 18, SC 13G 16, S-8 9, SCHEDULE 13G/A 9, UPLOAD 8, SCHEDULE 13G 7, 424B7 6, 10-K/A 5, 8-K/A 5, 10-Q/A 4, 3/A 4, CORRESP 4, SC 13D/A 4, 144 3, 8-A12G/A 1, DEFM14A 1, DEFR14A 1, EFFECT 1, NT 10-Q 1, PRE 14A 1, PREM14A 1, S-3 1, S-3/A 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 12:56 ET | [10-Q](/filings/0001628280-26-065423.md) | Quarterly report, period 2026-08-31 | 0001628280-26-065423 |
| 2026-10-08 | 08:16 ET | [DEF 14A](/filings/0001140361-26-039022.md) | Proxy statement, period 2026-11-17 | 0001140361-26-039022 |
| 2026-10-08 | 07:17 ET | [8-K](/filings/0001140361-26-039020.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-039020 |
| 2026-10-08 | 07:16 ET | [8-K](/filings/0001140361-26-039019.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-039019 |
| 2026-09-29 | 16:01 ET | [10-K/A](/filings/0001140361-26-037995.md) | Annual report, amended, period 2026-05-31 | 0001140361-26-037995 |
| 2026-09-29 | 09:14 ET | [10-K/A](/filings/0001140361-26-037943.md) | Annual report, amended, period 2026-05-31 | 0001140361-26-037943 |
| 2026-07-14 | 15:42 ET | [10-K](/filings/0001628280-26-048138.md) | Annual report, period 2026-05-31 | 0001628280-26-048138 |
| 2026-07-14 | 07:30 ET | [8-K](/filings/0001140361-26-028368.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-028368 |
| 2026-04-23 | 16:59 ET | [8-K](/filings/0001140361-26-016424.md) | 8.01 Other events | 0001140361-26-016424 |
| 2026-04-02 | 13:56 ET | [10-Q](/filings/0001628280-26-023008.md) | Quarterly report, period 2026-02-28 | 0001628280-26-023008 |
| 2026-04-02 | 07:30 ET | [8-K](/filings/0001140361-26-012891.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-012891 |
| 2026-02-03 | 17:20 ET | [8-K](/filings/0001140361-26-003518.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-003518 |
| 2026-01-14 | 07:33 ET | [8-K](/filings/0001140361-26-001154.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-001154 |
| 2026-01-06 | 15:19 ET | [10-Q](/filings/0001275187-26-000003.md) | Quarterly report, period 2025-11-30 | 0001275187-26-000003 |
| 2026-01-06 | 07:15 ET | [8-K](/filings/0001140361-26-000341.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-000341 |
| 2025-11-12 | 07:01 ET | [8-K](/filings/0001140361-25-041542.md) | 5.07 Shareholder vote results | 0001140361-25-041542 |
| 2025-10-02 | 16:07 ET | [10-Q](/filings/0001628280-25-043689.md) | Quarterly report, period 2025-08-31 | 0001628280-25-043689 |
| 2025-10-02 | 07:30 ET | [8-K](/filings/0001140361-25-037060.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-037060 |
| 2025-09-25 | 09:18 ET | [DEF 14A](/filings/0001628280-25-042704.md) | Proxy statement, period 2025-05-31 | 0001628280-25-042704 |
| 2025-07-18 | 10:38 ET | [10-K](/filings/0001275187-25-000014.md) | Annual report, period 2025-05-31 | 0001275187-25-000014 |
| 2025-07-15 | 07:16 ET | [8-K](/filings/0001140361-25-025835.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-025835 |
| 2025-05-28 | 16:01 ET | [8-K](/filings/0001140361-25-020621.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-25-020621 |
| 2025-04-02 | 14:14 ET | [10-Q](/filings/0001275187-25-000010.md) | Quarterly report, period 2025-02-28 | 0001275187-25-000010 |
| 2025-04-02 | 09:40 ET | [8-K](/filings/0001140361-25-011779.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-011779 |
| 2025-04-02 | 07:23 ET | [8-K](/filings/0001140361-25-011767.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-011767 |
| 2025-01-16 | 16:06 ET | [8-K](/filings/0001140361-25-001285.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-001285 |
| 2025-01-08 | 14:07 ET | [10-Q](/filings/0001275187-25-000005.md) | Quarterly report, period 2024-11-30 | 0001275187-25-000005 |
| 2025-01-08 | 08:00 ET | [8-K](/filings/0001140361-25-000538.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000538 |
| 2025-01-08 | 07:00 ET | [8-K](/filings/0001140361-25-000535.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000535 |
| 2024-11-15 | 16:05 ET | [8-K](/filings/0001140361-24-047071.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-24-047071 |
| 2024-10-03 | 17:08 ET | [10-Q](/filings/0001628280-24-042176.md) | Quarterly report, period 2024-08-31 | 0001628280-24-042176 |
| 2024-10-03 | 07:30 ET | [8-K](/filings/0001140361-24-042652.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-042652 |
| 2024-09-26 | 14:57 ET | [DEF 14A](/filings/0001628280-24-041344.md) | Proxy statement, period 2024-05-31 | 0001628280-24-041344 |
| 2024-07-25 | 16:13 ET | [10-K](/filings/0001628280-24-032989.md) | Annual report, period 2024-05-31 | 0001628280-24-032989 |
| 2024-07-16 | 07:22 ET | [8-K](/filings/0001140361-24-033242.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-033242 |
| 2024-07-16 | 07:15 ET | [8-K](/filings/0001140361-24-033240.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-033240 |
| 2024-04-09 | 17:08 ET | [10-Q](/filings/0001628280-24-015487.md) | Quarterly report, period 2024-02-29 | 0001628280-24-015487 |
| 2024-04-04 | 07:30 ET | [8-K](/filings/0001140361-24-017807.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-017807 |
| 2024-04-01 | 17:15 ET | [8-K](/filings/0001140361-24-016977.md) | 1.01 Entry into a material agreement | 0001140361-24-016977 |
| 2024-02-13 | 16:06 ET | [8-K](/filings/0001140361-24-007427.md) | 5.02 Departure or appointment of officers or directors | 0001140361-24-007427 |
| 2024-01-22 | 07:30 ET | [8-K](/filings/0001140361-24-002997.md) | 5.02 Departure or appointment of officers or directors | 0001140361-24-002997 |
| 2024-01-11 | 07:30 ET | [8-K](/filings/0001140361-24-001849.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-001849 |
| 2024-01-08 | 16:47 ET | [10-Q](/filings/0001628280-24-000857.md) | Quarterly report, period 2023-11-30 | 0001628280-24-000857 |
| 2024-01-05 | 07:15 ET | [8-K](/filings/0001140361-24-000830.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-000830 |
| 2023-11-16 | 20:02 ET | [8-K](/filings/0001140361-23-053522.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-23-053522 |
| 2023-10-05 | 17:15 ET | [10-Q](/filings/0001628280-23-033979.md) | Quarterly report, period 2023-08-31 | 0001628280-23-033979 |
| 2023-10-04 | 07:15 ET | [8-K](/filings/0001140361-23-046804.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-046804 |
| 2023-09-28 | 15:10 ET | [DEF 14A](/filings/0001628280-23-033186.md) | Proxy statement, period 2023-05-31 | 0001628280-23-033186 |
| 2023-08-03 | 17:16 ET | [10-K](/filings/0001628280-23-027335.md) | Annual report, period 2023-05-31 | 0001628280-23-027335 |
| 2023-07-24 | 16:15 ET | [8-K](/filings/0001140361-23-035863.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-23-035863 |

Page 1 of 7. [Older](/companies/ango/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:23 ET. No prices; not investment advice.